These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37428395)

  • 1. Exploring the glycolytic cross-talk genes between inflammatory bowel disease and colorectal cancer.
    Ye C; Huang Y; Gao Y; Zhu S; Yuan J
    Funct Integr Genomics; 2023 Jul; 23(3):230. PubMed ID: 37428395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of single-cell transcriptome reveals heterogeneity and commonality in the immune microenvironment of colorectal cancer and inflammatory bowel disease.
    Lv H; Mu Y; Zhang C; Zhao M; Jiang P; Xiao S; Sun H; Wu N; Sun D; Jin Y
    Front Immunol; 2024; 15():1356075. PubMed ID: 38529274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel immune cross-talk between inflammatory bowel disease and IgA nephropathy.
    Yan Q; Zhao Z; Liu D; Li J; Pan S; Duan J; Liu Z
    Ren Fail; 2024 Dec; 46(1):2337288. PubMed ID: 38628140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry.
    Adams SV; Ahnen DJ; Baron JA; Campbell PT; Gallinger S; Grady WM; LeMarchand L; Lindor NM; Potter JD; Newcomb PA
    World J Gastroenterol; 2013 Jun; 19(21):3241-8. PubMed ID: 23745025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer.
    Rajamäki K; Taira A; Katainen R; Välimäki N; Kuosmanen A; Plaketti RM; Seppälä TT; Ahtiainen M; Wirta EV; Vartiainen E; Sulo P; Ravantti J; Lehtipuro S; Granberg KJ; Nykter M; Tanskanen T; Ristimäki A; Koskensalo S; Renkonen-Sinisalo L; Lepistö A; Böhm J; Taipale J; Mecklin JP; Aavikko M; Palin K; Aaltonen LA
    Gastroenterology; 2021 Aug; 161(2):592-607. PubMed ID: 33930428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Profiling of Colorectal Carcinomas of Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    de Krijger M; Carvalho B; Rausch C; Bolijn AS; Delis-van Diemen PM; Tijssen M; van Engeland M; Mostafavi N; Bogie RMM; Dekker E; Masclee AAM; Verheij J; Meijer GA; Ponsioen CY
    Inflamm Bowel Dis; 2022 Sep; 28(9):1309-1320. PubMed ID: 35554535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and tumor immunity implication of inflammatory bowel disease-associated genes in colorectal cancer.
    Wang D; Xie B
    Eur J Med Res; 2022 Jun; 27(1):91. PubMed ID: 35698180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
    Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
    J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
    Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
    Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constructing a Tregs-associated signature to predict the prognosis of colorectal cancer patients: A STROBE-compliant retrospective study.
    Ping G; Tian Y; Zhou Z
    Medicine (Baltimore); 2022 Nov; 101(47):e31382. PubMed ID: 36451426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole blood ACTB, B2M and GAPDH expression reflects activity of inflammatory bowel disease, advancement of colorectal cancer, and correlates with circulating inflammatory and angiogenic factors: Relevance for real-time quantitative PCR.
    Bednarz-Misa I; Neubauer K; Zacharska E; Kapturkiewicz B; Krzystek-Korpacka M
    Adv Clin Exp Med; 2020 May; 29(5):547-556. PubMed ID: 32424999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease.
    Lutgens M; Vermeire S; Van Oijen M; Vleggaar F; Siersema P; van Assche G; Rutgeerts P; Oldenburg B;
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):148-54.e1. PubMed ID: 25041864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease.
    Ali RA; Dooley C; Comber H; Newell J; Egan LJ
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):584-9.e1-2. PubMed ID: 21565283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-Talk Between m
    Song W; Ren J; Xiang R; Yuan W; Fu T
    Front Immunol; 2022; 13():740960. PubMed ID: 35350786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelations of Apoptotic and Cellular Senescence Genes Methylation in Inflammatory Bowel Disease Subtypes and Colorectal Carcinoma in Egyptians Patients.
    Salama RH; Sayed ZEA; Ashmawy AM; Elsewify WA; Ezzat GM; Mahmoud MA; Alsanory AA; Alsanory TA
    Appl Biochem Biotechnol; 2019 Sep; 189(1):330-343. PubMed ID: 30989570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.
    Kim ER; Chang DK
    World J Gastroenterol; 2014 Aug; 20(29):9872-81. PubMed ID: 25110418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.
    Du L; Kim JJ; Shen J; Chen B; Dai N
    Oncotarget; 2017 Mar; 8(13):22175-22186. PubMed ID: 28077799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline Alterations in Patients With IBD-associated Colorectal Cancer.
    Biscaglia G; Latiano A; Castellana S; Fontana R; Gentile A; Latiano T; Corritore G; Panza A; Nardella M; Martino G; Bossa F; Perri F; Mazza T; Andriulli A; Palmieri O
    Inflamm Bowel Dis; 2022 Mar; 28(3):447-454. PubMed ID: 34347074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer.
    Chen Q; Tang P; Huang H; Qiu X
    Front Immunol; 2022; 13():934124. PubMed ID: 35958575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.